Some authors have reported that breast cancer cell lines infected with EBV have dysregulated HER2 and HER3 pathways [126]; other authors hypothesize that EBV infection may not be a causative agent, but rather infection during the course of the disease may alter the phenotype of the cancer, conferring a worse overall prognosis. Here, ERBB2 is linked to breast carcinoma.